CCA
Catalyst Capital Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,000
| Closed | -$796K | – | 368 |
|
|
2019
Q3 | $796K | Buy |
+8,000
| New | +$796K | 0.03% | 133 |
|
|
2016
Q3 | – | Sell |
-60,000
| Closed | -$7.16M | – | 442 |
|
|
2016
Q2 | $7.16M | Sell |
60,000
-7,000
| -10% | -$835K | 1.32% | 10 |
|
|
2016
Q1 | $7.18M | Hold |
67,000
| – | – | 1.21% | 24 |
|
|
2015
Q4 | $7.26M | Hold |
67,000
| – | – | 1.05% | 27 |
|
|
2015
Q3 | $5.74M | Buy |
+67,000
| New | +$5.74M | 0.77% | 42 |
|
|
2015
Q1 | – | Sell |
-37,000
| Closed | -$1.97M | – | 491 |
|
|
2014
Q4 | $1.97M | Buy |
37,000
+22,353
| +153% | +$1.19M | 0.23% | 96 |
|
|
2014
Q3 | $688K | Buy |
+14,647
| New | +$688K | 0.09% | 202 |
|